These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7904647)
21. Dopamine D1 and D2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata. Weed MR; Woolverton WL; Paul IA Eur J Pharmacol; 1998 Nov; 361(1):129-42. PubMed ID: 9851550 [TBL] [Abstract][Full Text] [Related]
22. Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity. Barton AC; Kang HC; Rinaudo MS; Monsma FJ; Stewart-Fram RM; Macinko JA; Haugland RP; Ariano MA; Sibley DR Brain Res; 1991 May; 547(2):199-207. PubMed ID: 1679366 [TBL] [Abstract][Full Text] [Related]
23. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat. Hilakivi I; Rinne J; Marjamäki P Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and binding properties of several new dopaminergic ligands. Tuce Z; Soskić V; Joksimović J Drug Des Discov; 1994 Jun; 11(4):251-8. PubMed ID: 7727678 [TBL] [Abstract][Full Text] [Related]
25. Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse. Amiri S; Amini-Khoei H; Mohammadi-Asl A; Alijanpour S; Haj-Mirzaian A; Rahimi-Balaei M; Razmi A; Olson CO; Rastegar M; Mehdizadeh M; Zarrindast MR Physiol Behav; 2016 Sep; 163():107-114. PubMed ID: 27143252 [TBL] [Abstract][Full Text] [Related]
26. trans-hexahydroindolo[4,3-ab]phenanthridines ("benzergolines"), the first structural class of potent and selective dopamine D1 receptor agonists lacking a catechol group. Seiler MP; Hagenbach A; Wüthrich HJ; Markstein R J Med Chem; 1991 Jan; 34(1):303-7. PubMed ID: 1671417 [TBL] [Abstract][Full Text] [Related]
27. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. Perachon S; Schwartz JC; Sokoloff P Eur J Pharmacol; 1999 Feb; 366(2-3):293-300. PubMed ID: 10082211 [TBL] [Abstract][Full Text] [Related]
28. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs. Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022 [TBL] [Abstract][Full Text] [Related]
30. In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors. Fenu S; Espa E; Pisanu A; Di Chiara G Eur J Pharmacol; 2016 Oct; 788():183-191. PubMed ID: 27343381 [TBL] [Abstract][Full Text] [Related]
31. Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor. Torvinen M; Kozell LB; Neve KA; Agnati LF; Fuxe K J Mol Neurosci; 2004; 24(2):173-80. PubMed ID: 15456930 [TBL] [Abstract][Full Text] [Related]
32. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Engber TM; Marin C; Susel Z; Chase TN Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles. Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766 [TBL] [Abstract][Full Text] [Related]
34. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity. Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566 [TBL] [Abstract][Full Text] [Related]
38. Synergistic effect of D1 and D2 dopamine receptors on AP-1 DNA-binding activity in the striatum and globus pallidus of the rat with a unilateral 6-OHDA lesion of the medical forebrain bundle. Kashihara K; Akiyama K; Ishihara T; Shiro Y; Shohmori T Life Sci; 1996; 59(20):1683-93. PubMed ID: 8890942 [TBL] [Abstract][Full Text] [Related]
39. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors. Reader TA; Molina-Holgado E; Dewar KM Mol Neurobiol; 1992; 6(4):425-50. PubMed ID: 1285933 [TBL] [Abstract][Full Text] [Related]
40. Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors. Auteri M; Zizzo MG; Amato A; Serio R J Physiol Biochem; 2016 Aug; 73(3):395-404. PubMed ID: 28600746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]